These collectives, formed to funnel money to athletes or schools, fail to meet NCAA rules requiring deals to serve a valid business purpose.

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...